Sydney Finkelstein

Sydney Finkelstein

Corporate Officer/Principal at INTERPACE BIOSCIENCES, INC.
Consumer Services
Health Technology
Health Services

Profile

Sydney D.
Finkelstein
is the founder of Redpath Partners, Inc. Current positions include Chief Pathology Officer at Interpace Biosciences, Inc., Adjunct Professor at Temple University (Pennsylvania), Consultant at Jackson Leadership Systems, Inc., and Professor at Drexel University.
Former positions include Faculty Member at Dartmouth College, Duke University, Northwestern University, The University of New South Wales, Aalto University, and London Business School; Professor at the University of Pittsburgh and Hahnemann University.
Education includes a doctorate from The Trustees of Columbia University in The City of New York, an undergraduate degree from Concordia University, and a graduate degree from the London School of Economics & Political Science.

Sydney Finkelstein active positions

CompaniesPositionStart
INTERPACE BIOSCIENCES, INC. Corporate Officer/Principal -
Corporate Officer/Principal -
Founder -
Corporate Officer/Principal -
Corporate Officer/Principal -

Former positions of Sydney Finkelstein

CompaniesPositionEnd
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
See the detail of Sydney Finkelstein's experience

Training of Sydney Finkelstein

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

84

1st degree connections

16

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies16

Health Technology

Health Services

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Consumer Services

Consumer Services

Consumer Services

Consumer Services

  1. Stock Market
  2. Insiders
  3. Sydney Finkelstein
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!